October 27, 2020
FDA drafting protocols to track COVID-19 vaccine safety
Editor's Note
The Food and Drug Administration’s (FDA’s) Office of Biostatistics and Epidemiology is currently developing master protocols to be used in monitoring the safety and effectiveness of a COVID-19 vaccine once it is authorized or approved, in addition to postmarket surveillance requirements, the October 22 Regulatory Focus reports.
The FDA will draw on big data resources and the Centers for Disease Control and Prevention to follow the vaccines’ track records.
The protocols will be posted for public comment.
Free Daily News
- AI boosts accuracy in surgical reports, outperforming surgeons
- AI models improve prediction of surgical complications using preoperative clinical notes
- Ambient AI healthcare documentation gains traction as capabilities expand
- Healthcare M&A faces tighter review as FTC retains guidelines
- Healthcare giants prioritize shareholder payouts over patient care
- Texas abortion ban linked to spike in pregnancy complications, maternal death
- AI streamlines documentation, frees time for nurses at Cedars-Sinai surgical unit
- Study identifies potential non-surgical treatment for inguinal hernias
- Rural hospital closures remain a growing concern despite slight financial improvement
- Session: Hoisting the Sails—Winning Strategies for Growing Service Lines in an ASC
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement